Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

por Ito, Koichi, Scott, Stacy A., Cutler, Samuel, Dong, Lan-Feng, Neuzil, Jiri, Blanchard, Helen, Ralph, Stephen J.
Publicado 2011